Sue Decotiis, M.D., a triple board-certified physician in internal medicine, antiaging medicine, and obesity medicine, who leads a weight-loss practice in Scarsdale, NY
The phase 3 SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) clinical trial program evaluated the efficacy and safety of semaglutide in subjects with T2D in a range of patient populations across the continuum of diabetes care [7,8,9,10,11,12,13,14]
350 ug of DNA was taken for bisulfite conversion through EpiTect Fast DNA Methylation Kit (Qiagen cat#59824) according to the instructions from manufacturer
When tested head-to-head, outcomes may vary based on individual health conditions, gender, and other demographic factors
Now that the shortage is over, though, the FDA has withdrawn that approval